• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Atherosclerosis Partnering 2009-2014 Product Image

Atherosclerosis Partnering 2009-2014

  • ID: 2074742
  • November 2014
  • Region: Global
  • 100 Pages
  • CurrentPartnering

FEATURED COMPANIES

  • Abbott
  • Baxter International
  • Dainippon Sumitomo
  • Grifols
  • Mitsubishi Tanabe
  • Servier
  • MORE

Atherosclerosis Partnering 2009-2014 provides understanding and access to the atherosclerosis partnering deals and agreements entered into by the worlds leading healthcare companies.

The report provides an analysis of atherosclerosis partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors atherosclerosis technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases do not.

This data driven report contains over 25 links to online copies of actual atherosclerosis deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners, where available. READ MORE >

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott
  • Baxter International
  • Dainippon Sumitomo
  • Grifols
  • Mitsubishi Tanabe
  • Servier
  • MORE

Executive Summary

Chapter 1 – Introduction

Chapter 2 – Trends in atherosclerosis partnering

2.1. Introduction
2.2. Atherosclerosis partnering over the years
2.3. Big pharma atherosclerosis dealmaking activity
2.4. Big biotech atherosclerosis dealmaking activity
2.5. Most active atherosclerosis dealmakers
2.6. Atherosclerosis partnering by deal type
2.7. Atherosclerosis partnering industry sector
2.8. Atherosclerosis partnering by stage of development
2.9. Atherosclerosis partnering by technology type
2.10. Disclosed financial deal terms for atherosclerosis
2.10.1 Atherosclerosis headline values
2.10.2 Atherosclerosis upfront payments
2.10.3 Atherosclerosis milestone payments
2.10.4 Atherosclerosis royalty rates

Chapter 3 – Leading atherosclerosis deals

3.1. Introduction
3.2. Top atherosclerosis deals by value

Chapter 4 – Dealmaking directory

4.1. Introduction
4.2. Company A-Z
4.3. By deal type
4.4. By industry sector
4.5. By stage of development
4.6. By technology type

Chapter 5 – Partnering resource center

5.1. Online partnering
5.2. Partnering events
5.3. Further reading on dealmaking

Appendices

Appendix 1 – Deal type definitions

Recent report titles from
Order Form – Subscription Access Products

Table of figures

Figure 1: Atherosclerosis partnering since 2009
Figure 2: Big pharma – top 50 – atherosclerosis deals 2009 to 2014
Figure 3: Big pharma atherosclerosis deal frequency – 2009 to 2014
Figure 4: Big biotech – top 50 – atherosclerosis deals 2009 to 2014
Figure 5: Big biotech atherosclerosis deal frequency – 2009 to 2014
Figure 6: Atherosclerosis dealmaking activity– 2009 to 2014
Figure 7: Atherosclerosis partnering by deal type since 2009
Figure 8: Atherosclerosis partnering by industry sector since 2009
Figure 9: Atherosclerosis partnering by stage of development since 2009
Figure 10: Atherosclerosis partnering by technology type since 2009
Figure 11: Atherosclerosis deals with a headline value
Figure 12: Atherosclerosis deals with upfront payment values
Figure 13: Atherosclerosis deals with milestone payments
Figure 14: Atherosclerosis deals with royalty rates, %
Figure 15: Top atherosclerosis deals by value since 2009
Figure 16: Online partnering resources
Figure 17: Forthcoming partnering events
Figure 18: Deal type definitions

Note: Product cover images may vary from those shown

Abbott
Actavis
Actelion
Allergan
Amgen
Aspen Pharmacare
Astellas
AstraZeneca
Baxter International
Bayer
Biogen Idec
Boehringer Ingelheim
Bristol-Myers Squibb
Celgene
CSL
Daiichi Sankyo
Dainippon Sumitomo
Eisai
Eli Lilly
Endo Pharmaceuticals
Forest Laboratories
Galderma
Gilead Sciences
GlaxoSmithKline
Grifols
Hospira
Johnson & Johnson
Kyowa Hakko Kirin
Lundbeck
Menarini
Merck & Co
Merck KGaA
Mitsubishi Tanabe
Novartis
Novo Nordisk
Otsuka
Pfizer
Purdue
Roche
Sanofi
Servier
Shionogi
Shire
Takeda
Teva
Valeant
Warner Chilcott
Watson

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

  • Pharma and Biotech M&A Trends 2009-2014 [old name Merger & Acquisition Terms and Agreements] - Product Thumbnail Image Pharma and Biotech M&A Trends 2009-2014 [old name Merger & Acquisition Terms and Agreements]

    Pharma and Biotech M&A Trends 2009-2014 [old name Merger & Acquisition Terms and Agreements]

    • Language: English
    • 1677 Pages
    • Published: July 2014
    • Region: Global
    FROM
  • Cardiovascular Partnering Terms and Agreements - Product Thumbnail Image Cardiovascular Partnering Terms and Agreements

    Cardiovascular Partnering Terms and Agreements

    • Language: English
    • 493 Pages
    • Published: August 2014
    • Region: Global
    FROM
  • Trends in Therapeutic Partnering - Product Thumbnail Image

    Trends in Therapeutic Partnering

    • Language: English
    • 3562 Pages
    • Published: August 2014
    • Region: Global
    FROM
  • Discovery Stage Partnering Terms and Agreements - Product Thumbnail Image Discovery Stage Partnering Terms and Agreements

    Discovery Stage Partnering Terms and Agreements

    • Language: English
    • 3081 Pages
    • Published: September 2014
    • Region: Global
    FROM
  • Lung Cancer Partnering 2009-2014 - Product Thumbnail Image Lung Cancer Partnering 2009-2014

    Lung Cancer Partnering 2009-2014

    • Language: English
    • 250 Pages
    • Published: November 2014
    • Region: Global
    FROM
  • Diabetes Partnering 2009-2014 - Product Thumbnail Image Diabetes Partnering 2009-2014

    Diabetes Partnering 2009-2014

    • Language: English
    • 300 Pages
    • Published: November 2014
    • Region: Global
    FROM
  • Influenza Partnering 2009-2014 - Product Thumbnail Image Influenza Partnering 2009-2014

    Influenza Partnering 2009-2014

    • Language: English
    • 100 Pages
    • Published: November 2014
    • Region: Global
    FROM
  • HIV Partnering 2009-2014 - Product Thumbnail Image HIV Partnering 2009-2014

    HIV Partnering 2009-2014

    • Language: English
    • Published: November 2014
    • Region: Global
    FROM
  • Leukemia Partnering 2009-2014 - Product Thumbnail Image Leukemia Partnering 2009-2014

    Leukemia Partnering 2009-2014

    • Language: English
    • 200 Pages
    • Published: November 2014
    • Region: Global
    FROM
  • Breast Cancer Partnering 2009-2014 - Product Thumbnail Image Breast Cancer Partnering 2009-2014

    Breast Cancer Partnering 2009-2014

    • Language: English
    • 245 Pages
    • Published: November 2014
    • Region: Global
    FROM

Our Clients

AB Sciex Eli Lilly and Company B. Braun Melsungen AG Astellas Pharma, Inc. Hologic Corporation Merck & Co., Inc.